
Yantai Zhenghai Biotechnology Co., Ltd.
SZSE:300653.SZ
27.39 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 363.225 | 413.653 | 433.225 | 400.175 | 293.282 | 279.807 | 215.544 | 182.782 | 150.623 | 128.133 | 105.305 | 77.377 | 59.296 |
Cost of Revenue
| 44.885 | 41.774 | 48.855 | 43.596 | 22.795 | 19.252 | 14.921 | 11.562 | 10.859 | 7.668 | 6.424 | 6.249 | 3.732 |
Gross Profit
| 318.34 | 371.878 | 384.369 | 356.579 | 270.487 | 260.555 | 200.623 | 171.22 | 139.763 | 120.465 | 98.881 | 71.128 | 55.564 |
Gross Profit Ratio
| 0.876 | 0.899 | 0.887 | 0.891 | 0.922 | 0.931 | 0.931 | 0.937 | 0.928 | 0.94 | 0.939 | 0.919 | 0.937 |
Reseach & Development Expenses
| 39.522 | 44.048 | 37.549 | 35.18 | 26.573 | 21.397 | 16.634 | 16.421 | 12.712 | 13.781 | 12.486 | 6.755 | 0 |
General & Administrative Expenses
| 6.594 | 7.07 | 8.427 | 10.749 | 8.764 | 7.631 | 6.667 | 8.031 | 10.929 | 10.86 | 5.622 | 14.177 | 11.186 |
Selling & Marketing Expenses
| 96.992 | 78.04 | 116.917 | 122.148 | 104.391 | 110.74 | 83.569 | 76.303 | 64.001 | 48.328 | 41.504 | 38.771 | 30.506 |
SG&A
| 103.586 | 85.109 | 125.344 | 132.897 | 113.156 | 118.371 | 90.236 | 84.334 | 74.93 | 59.188 | 47.126 | 52.948 | 41.691 |
Other Expenses
| 22.725 | 0 | 0.035 | -0.248 | 2.772 | 0.623 | 0.068 | 1.382 | 6.988 | 9.221 | 8.537 | 4.672 | 1.315 |
Operating Expenses
| 165.833 | 153.307 | 179.211 | 182.027 | 147.453 | 151.083 | 116.032 | 108.769 | 97.106 | 81.276 | 66.204 | 53.552 | 42.155 |
Operating Income
| 152.507 | 218.571 | 212.073 | 191.826 | 133.712 | 123.496 | 99.377 | 70.605 | 44.637 | 40.034 | 31.674 | 13.906 | 8.571 |
Operating Income Ratio
| 0.42 | 0.528 | 0.49 | 0.479 | 0.456 | 0.441 | 0.461 | 0.386 | 0.296 | 0.312 | 0.301 | 0.18 | 0.145 |
Total Other Income Expenses Net
| -0.129 | -0.175 | 0.035 | -0.248 | 2.772 | 18.052 | 18.362 | 1.382 | 9.007 | 11.101 | 7.695 | 4.652 | 1.293 |
Income Before Tax
| 152.378 | 218.396 | 212.108 | 191.579 | 136.484 | 124.119 | 99.445 | 71.987 | 53.643 | 50.171 | 39.369 | 18.557 | 9.864 |
Income Before Tax Ratio
| 0.42 | 0.528 | 0.49 | 0.479 | 0.465 | 0.444 | 0.461 | 0.394 | 0.356 | 0.392 | 0.374 | 0.24 | 0.166 |
Income Tax Expense
| 17.739 | 27.438 | 26.671 | 23.026 | 18.15 | 16.733 | 13.63 | 10.317 | 8.173 | 7.679 | 5.709 | 2.79 | 1.349 |
Net Income
| 134.639 | 190.958 | 185.437 | 168.553 | 118.334 | 107.386 | 85.815 | 61.67 | 45.47 | 42.492 | 33.66 | 15.767 | 8.515 |
Net Income Ratio
| 0.371 | 0.462 | 0.428 | 0.421 | 0.403 | 0.384 | 0.398 | 0.337 | 0.302 | 0.332 | 0.32 | 0.204 | 0.144 |
EPS
| 0.75 | 1.06 | 1.28 | 0.94 | 0.66 | 0.59 | 0.48 | 0.38 | 0.34 | 0.35 | 0.63 | 0 | 0 |
EPS Diluted
| 0.75 | 1.06 | 1.28 | 0.94 | 0.66 | 0.59 | 0.48 | 0.38 | 0.34 | 0.35 | 0.63 | 0 | 0 |
EBITDA
| 174.982 | 239.621 | 231.947 | 209.538 | 142.665 | 129.63 | 104.398 | 76.189 | 46.379 | 42.466 | 35.5 | 17.576 | 13.409 |
EBITDA Ratio
| 0.482 | 0.579 | 0.535 | 0.524 | 0.486 | 0.463 | 0.484 | 0.417 | 0.308 | 0.331 | 0.337 | 0.227 | 0.226 |